ARTICLE | Company News

Norgine, Applied Pharma Research sales and marketing update

January 23, 2012 8:00 AM UTC

Applied Pharma Research granted Norgine commercialization rights to Setofilm ondansetron in Europe and certain countries in the Middle East, Africa, and Australasia. Setofilm is a dissolving oral film strip formulation of ondansetron using RapidFilm technology that is approved in 16 European countries to treat and prevent chemotherapy- and radiation-induced nausea and vomiting and post-operative nausea and vomiting (PONV). Terms were not disclosed. ...